DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Arhalofenate is an investigational drug.
There have been 5 clinical trials for Arhalofenate. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2014.
The most common disease conditions in clinical trials are Gout, Hyperuricemia, and [disabled in preview]. The leading clinical trial sponsors are CymaBay Therapeutics, Inc. and [disabled in preview].
There are fifty-three US patents protecting this investigational drug and six hundred and forty-nine international patents.
Recent Clinical Trials for Arhalofenate
|Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout||CymaBay Therapeutics, Inc.||Phase 2|
|Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients||CymaBay Therapeutics, Inc.||Phase 2|
|Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients||CymaBay Therapeutics, Inc.||Phase 2|
Top disease conditions for Arhalofenate
Top clinical trial sponsors for Arhalofenate
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Arhalofenate||⤷ Sign up for a Free Trial||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||⤷ Sign up for a Free Trial|
|Arhalofenate||⤷ Sign up for a Free Trial||Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators||Pfizer Inc. (New York, NY)||⤷ Sign up for a Free Trial|
|Arhalofenate||⤷ Sign up for a Free Trial||Heterocyclic compound||Takeda Pharmaceutical Company Limited (Osaka, JP)||⤷ Sign up for a Free Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Arhalofenate||Australia||AU2017261372||2036-05-05||⤷ Sign up for a Free Trial|
|Arhalofenate||Canada||CA3023278||2036-05-05||⤷ Sign up for a Free Trial|
|Arhalofenate||China||CN107847398||2036-05-05||⤷ Sign up for a Free Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|